AstraZeneca CEO Sir Pascal Soriot criticizes NICE’s methodology for denying cancer patients access to necessary drugs

AstraZeneca CEO Criticizes Refusal of Breast Cancer Treatment by Public Health Body The chief executive of AstraZeneca, Sir Pascal Soriot, has expressed disappointment over the decision of the National Institute for Health and Care Excellence (NICE) to deny access to the company’s breast cancer treatment, Enhertu, for NHS patients in England and Wales. According to NICE, the drug did not provide…

Source

AstraZeneca CEO Sir Pascal Soriot criticizes NICE’s methodology for denying cancer patients access to necessary drugs

Sir Vince Cable takes partial responsibility for Post Office scandal

Cineworld Announces Massive Job Cuts as Part of Major Restructuring Effort

Cineworld Announces Massive Job Cuts as Part of Major Restructuring Effort

Gold Prices Rise as the Dollar Slowly Dies

An Unraveling, Secession, or WWIII?

Mike Lynch’s extradition from the US and unsuccessful prosecution: What we can learn from the stacked odds

SmallRig and RECnGO Collaborate to Enhance Mobile Video Production Efficiency

Could an Increase in the Supply of Gold Cause a Boom-Bust Cycle?

Ana-Maria Coaching Marks Milestone with New Book Release

The Consequences of California’s New Minimum Wage Law

Memorial Day

Could an Increase in the Supply of Gold Cause a Boom-Bust Cycle?

Election Policy Roundup

GMF Group (Led by Matthew Forssman and Gabriel Monfried) Acquires Moonrise Resort, Floral City, Florida

Only 48 Percent of Employment-Based Green Cards Went to Workers in 2023: Here’s How to Fix That

Recent News

Could an Increase in the Supply of Gold Cause a Boom-Bust Cycle?

Election Policy Roundup

GMF Group (Led by Matthew Forssman and Gabriel Monfried) Acquires Moonrise Resort, Floral City, Florida

Only 48 Percent of Employment-Based Green Cards Went to Workers in 2023: Here’s How to Fix That